Mental Health Supports for Sexual and Gender Minorities Who Experience Intimate Partner Violence and Abuse: A Systematic Review of North American Literature.

Trauma Violence AbuseSep 20, 2025 (epub)
Clinical ResearchPsychiatry

Stefan Kurbatfinski, Katherine Maurer, Jessica Whitehead et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review synthesized North American research on how sexual and gender minorities (SGM) who experienced intimate partner violence and abuse (IPV) sought and experienced mental health support. Using meta-aggregative methods, it identified four themes across studies from the United States and Canada: affirming spaces, provider characteristics, the healing process, and community awareness of services. Mental health providers, excluding couples’ counselors, were described as supportive, helping clients develop skills to manage or leave abusive relationships. Inclusive language, provider training on SGM-specific IPV, and strong client-provider rapport were identified as important features of support.

Key findings

  • The review identified four synthesized themes: affirming spaces, mental health provision, the healing journey, and community awareness of services.
  • Mental health providers, excluding couples’ counselors, were described as supporting self-development and skills to manage or leave abusive relationships.
  • Inclusive language in SGM-affirming spaces was associated with greater comfort discussing IPV with mental health providers.
  • Training on SGM-specific IPV and client-provider rapport were identified as important features of effective support.

Why it matters

SGM experiencing IPV may face both abuse and discrimination when seeking help. The review highlights how affirming communication, provider understanding of SGM-specific IPV, and a trusting therapeutic relationship can shape access to and experience of mental health support. These findings can inform efforts to make services more responsive to this population.

What to keep in mind

The review is limited to peer-reviewed North American literature, and the abstract does not report quantitative estimates of support effectiveness.

Source

Published in Trauma Violence Abuse. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.